News & Updates

Show Multimedia Only
Eosinophil levels do not influence outcomes with triple combo asthma inhaler
Eosinophil levels do not influence outcomes with triple combo asthma inhaler
07 Jul 2023

Treatment with fixed-dose asthma inhaler combination of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) helps improve lung function and reduce exacerbations as compared with MF/IND and fluticasone/salmeterol (FLU/SAL), regardless of baseline eosinophil levels, according to a post hoc analysis of the IRIDIUM study.

Eosinophil levels do not influence outcomes with triple combo asthma inhaler
07 Jul 2023